Viewing Study NCT04139993


Ignite Creation Date: 2025-12-25 @ 1:25 AM
Ignite Modification Date: 2025-12-31 @ 2:33 PM
Study NCT ID: NCT04139993
Status: TERMINATED
Last Update Posted: 2023-10-04
First Post: 2019-10-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: RBX7455 Before Surgery for the Treatment of Operable Breast Cancer
Sponsor: Mayo Clinic
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Anatomic Stage I Breast Cancer AJCC v8 View
None Anatomic Stage IA Breast Cancer AJCC v8 View
None Anatomic Stage IB Breast Cancer AJCC v8 View
None Anatomic Stage II Breast Cancer AJCC v8 View
None Anatomic Stage IIA Breast Cancer AJCC v8 View
None Anatomic Stage IIB Breast Cancer AJCC v8 View
None Anatomic Stage III Breast Cancer AJCC v8 View
None Anatomic Stage IIIA Breast Cancer AJCC v8 View
None Anatomic Stage IIIB Breast Cancer AJCC v8 View
None Anatomic Stage IIIC Breast Cancer AJCC v8 View
None Breast Adenocarcinoma View
None Invasive Breast Carcinoma View
None Prognostic Stage I Breast Cancer AJCC v8 View
None Prognostic Stage IA Breast Cancer AJCC v8 View
None Prognostic Stage IB Breast Cancer AJCC v8 View
None Prognostic Stage II Breast Cancer AJCC v8 View
None Prognostic Stage IIA Breast Cancer AJCC v8 View
None Prognostic Stage IIB Breast Cancer AJCC v8 View
None Prognostic Stage III Breast Cancer AJCC v8 View
None Prognostic Stage IIIA Breast Cancer AJCC v8 View
None Prognostic Stage IIIB Breast Cancer AJCC v8 View
None Prognostic Stage IIIC Breast Cancer AJCC v8 View
None Triple-Negative Breast Carcinoma View
Keywords: